Clinical trial
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
NCT02397668 is registered in ClinicalTrials.gov with Corvivo Cardiovascular, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- Lead sponsor
- Corvivo Cardiovascular, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2022
- Completion date
- December 15, 2026
- Enrollment
- 78 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
tricuspid valve disease